Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SPONSORED ADR
-
Total 13F shares
-
9,832,663
-
Share change
-
+1,082,268
-
Total reported value
-
$7,680,000
-
Price per share
-
$0.78
-
Number of holders
-
9
-
Value change
-
+$815,003
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of FORWARD PHARMA A/S - SPONSORED ADR (FWP) as of Q4 2018
As of 31 Dec 2018,
FORWARD PHARMA A/S - SPONSORED ADR (FWP) was held by
9 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,832,663 shares.
The largest 9 holders included
BVF INC/IL, Newtyn Management, LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SEI INVESTMENTS CO, UBS Group AG, and DEUTSCHE BANK AG\.
This page lists
9
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.